vs
Solowin Holdings, Ltd.（AXG）与PULSE BIOSCIENCES, INC.（PLSE）财务数据对比。点击上方公司名可切换其他公司
Solowin Holdings, Ltd.的季度营收约是PULSE BIOSCIENCES, INC.的1.6倍（$410.0K vs $264.0K），Solowin Holdings, Ltd.自由现金流更多（$-1.6M vs $-14.9M）
Colossal Biosciences是一家美国生物技术与基因工程公司，核心研究方向是通过基因技术让猛犸象、袋狼、北白犀、恐狼、渡渡鸟、恐鸟等已灭绝物种复活。该公司目标在2028年前培育出猛犸象杂交后代，并计划将其重新引入北极苔原栖息地，同时也启动了袋狼相关研究项目。
AXG vs PLSE — 直观对比
营收规模更大
AXG
是对方的1.6倍
$264.0K
自由现金流更多
AXG
多$13.2M
$-14.9M
损益表 — Q2 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $410.0K | $264.0K |
| 净利润 | — | $-17.4M |
| 毛利率 | — | — |
| 营业利润率 | -34.1% | -6914.0% |
| 净利率 | — | -6603.4% |
| 营收同比 | — | — |
| 净利润同比 | — | 10.1% |
| 每股收益（稀释后） | — | — |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收AXGPLSE
| Q4 25 | — | $264.0K | ||
| Q3 25 | — | $86.0K | ||
| Q2 25 | — | $0 | ||
| Q1 25 | — | $0 | ||
| Q4 24 | — | $0 | ||
| Q3 24 | $410.0K | $0 | ||
| Q2 24 | — | $0 | ||
| Q1 24 | — | $0 |
净利润AXGPLSE
| Q4 25 | — | $-17.4M | ||
| Q3 25 | — | $-19.4M | ||
| Q2 25 | — | $-19.2M | ||
| Q1 25 | — | $-16.8M | ||
| Q4 24 | — | $-19.4M | ||
| Q3 24 | — | $-12.7M | ||
| Q2 24 | — | $-11.4M | ||
| Q1 24 | — | $-10.1M |
毛利率AXGPLSE
| Q4 25 | — | — | ||
| Q3 25 | — | -224.4% | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
营业利润率AXGPLSE
| Q4 25 | — | -6914.0% | ||
| Q3 25 | — | -23682.6% | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | -34.1% | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
净利率AXGPLSE
| Q4 25 | — | -6603.4% | ||
| Q3 25 | — | -22540.7% | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $2.5M | $80.7M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $6.0M | $80.7M |
| 总资产 | $13.1M | $94.5M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资AXGPLSE
| Q4 25 | — | $80.7M | ||
| Q3 25 | — | $95.2M | ||
| Q2 25 | — | $106.3M | ||
| Q1 25 | — | $119.3M | ||
| Q4 24 | — | $118.0M | ||
| Q3 24 | $2.5M | $79.0M | ||
| Q2 24 | — | $26.2M | ||
| Q1 24 | — | $34.9M |
股东权益AXGPLSE
| Q4 25 | — | $80.7M | ||
| Q3 25 | — | $92.7M | ||
| Q2 25 | — | $104.5M | ||
| Q1 25 | — | $118.5M | ||
| Q4 24 | — | $114.9M | ||
| Q3 24 | $6.0M | $79.1M | ||
| Q2 24 | — | $27.0M | ||
| Q1 24 | — | $36.3M |
总资产AXGPLSE
| Q4 25 | — | $94.5M | ||
| Q3 25 | — | $108.8M | ||
| Q2 25 | — | $120.3M | ||
| Q1 25 | — | $133.4M | ||
| Q4 24 | — | $132.5M | ||
| Q3 24 | $13.1M | $93.0M | ||
| Q2 24 | — | $40.4M | ||
| Q1 24 | — | $49.2M |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-1.6M | $-14.8M |
| 自由现金流经营现金流 - 资本支出 | $-1.6M | $-14.9M |
| 自由现金流率自由现金流/营收 | -392.9% | -5628.8% |
| 资本支出强度资本支出/营收 | 4.4% | 39.8% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | $-54.4M |
8季度趋势，按日历期对齐
经营现金流AXGPLSE
| Q4 25 | — | $-14.8M | ||
| Q3 25 | — | $-13.0M | ||
| Q2 25 | — | $-12.8M | ||
| Q1 25 | — | $-13.5M | ||
| Q4 24 | — | $-9.1M | ||
| Q3 24 | $-1.6M | $-9.0M | ||
| Q2 24 | — | $-8.4M | ||
| Q1 24 | — | $-9.8M |
自由现金流AXGPLSE
| Q4 25 | — | $-14.9M | ||
| Q3 25 | — | $-13.1M | ||
| Q2 25 | — | $-12.9M | ||
| Q1 25 | — | $-13.6M | ||
| Q4 24 | — | $-9.2M | ||
| Q3 24 | $-1.6M | $-9.1M | ||
| Q2 24 | — | $-8.4M | ||
| Q1 24 | — | $-9.8M |
自由现金流率AXGPLSE
| Q4 25 | — | -5628.8% | ||
| Q3 25 | — | -15233.7% | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | -392.9% | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
资本支出强度AXGPLSE
| Q4 25 | — | 39.8% | ||
| Q3 25 | — | 72.1% | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 4.4% | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
